Effects of Itraconazole on the Plasma Kinetics of Quazepam and Its Two Active Metabolites after a Single Oral Dose of the Drug
Effects of Itraconazole on the Plasma Kinetics of Quazepam and Its Two Active Metabolites after a Single Oral Dose of the Drug
复制标题
单次口服药物后伊曲康唑对夸西泮及其两种活性代谢物血浆动力学的影响
DOI:
10.1097/00007691-200308000-00010
复制
发表时间:
2003
影响因子:
2.5
通讯作者:
K. Otani
中科院分区:
文献类型:
--
作者:
Kimiyasu Kato;N. Yasui‐Furukori;T. Fukasawa;T. Aoshima;A. Suzuki;Muneaki Kanno;K. Otani
&NA; The effects of itraconazole, a potent inhibitor of cytochrome P450 (CYP) 3A4, on the plasma kinetics of quazepam and its two active metabolites after a single oral dose of the drug were studied. Ten healthy male volunteers received itraconazole 100 mg/d or placebo for 14 days in a double‐blind randomized crossover manner, and on the fourth day of the treatment they received a single oral 20‐mg dose of quazepam. Blood samplings and evaluation of psychomotor function by the Digit Symbol Substitution Test and Stanford Sleepiness Scale were conducted up to 240 h after quazepam dosing. Itraconazole treatment did not change the plasma kinetics of quazepam but significantly decreased the peak plasma concentration and area under the plasma concentration‐time curve of 2‐oxoquazepam and N‐desalkyl‐2‐oxoquazepam. Itraconazole treatment did not affect either of the psychomotor function parameters. The present study thus suggests that CYP 3A4 is partly involved in the metabolism of quazepam.